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Abstract
Background: The traditional evaluation of gait in the laboratory during structured testing has provided important
insights, but is limited by its “snapshot” character and observation in an unnatural environment. Wearables enable
monitoring of gait in real-world environments over a week. Initial findings show that in-lab and real-world
measures differ. As a step towards better understanding these gaps, we directly compared in-lab usual-walking
(UW) and dual-task walking (DTW) to daily-living measures of gait.
Methods: In-lab gait features (e.g., gait speed, step regularity, and stride regularity) derived from UW and DTW were
compared to the same gait features during daily-living in 150 elderly fallers (age: 76.5 ± 6.3 years, 37.6% men). In both
settings, features were extracted from a lower-back accelerometer. In the real-world setting, subjects were asked to wear
the device for 1 week and pre-processing detected 30-s daily-living walking bouts. A histogram of all walking bouts was
determined for each walking feature for each subject and then each subject’s typical (percentile 50, median), worst
(percentile 10) and the best (percentile 90) values over the week were determined for each feature. Statistics of reliability
were assessed using Intra-Class correlations and Bland-Altman plots.
Results: As expected, in-lab gait speed, step regularity, and stride regularity were worse during DTW, compared to UW.
In-lab gait speed, step regularity, and stride regularity during UW were significantly higher (i.e., better) than the typical
daily-living values (p < 0.001) and different (p < 0.001) from the worst and best values. DTW values tended to be similar to
typical daily-living values (p = 0.205, p = 0.053, p = 0.013 respectively). ICC assessment and Bland-Altman plots indicated
that in-lab values do not reliably reflect the daily-walking values.
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Conclusions: Gait values measured during relatively long (30-s) daily-living walking bouts are more similar to the
corresponding values obtained in the lab during dual-task walking, as compared to usual walking. Still, gait performance
during most daily-living walking bouts is worse than that measured during usual and dual-tasking in the lab. The values
measured in the lab do not reliably reflect daily-living measures. That is, an older adult’s typical daily-living gait cannot be
estimated by simply measuring walking in a structured, laboratory setting.
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Background
Among older adults, gait is one of the keys to functional in-
dependence and gait changes are associated with and pre-
dictive of numerous adverse health outcomes. These
include falls, mobility disability, cognitive decline, dementia,
and even mortality [1–3]. Until recently, gait assessments
were generally conducted in specialized laboratory facilities,
under well-defined, scripted conditions. These tests pro-
vided important insight into gait impairments in aging and
pathology [4–14]. Cognitive “dual tasking” paradigms were
added to enhance short, in-lab testing in an attempt to
make the tests more reflective of the many motor-cognitive
challenges that occur during every-day ambulation [15–26].
Dual-tasking studies demonstrated that in older adults,
people with neurodegenerative diseases, and many other
cohorts with impaired walking abilities, gait speed is re-
duced, gait variability becomes larger, and asymmetry often
increases. At the same time, there is increased reliance on
cortical function, in particular, the pre-frontal cortex, dur-
ing walking [27–31]. Dual-task walking abilities and this in-
creased pre-frontal cortex activation have also been related
to fall risk [17, 32]. This suggests that during every-day
walking, when many secondary tasks provide challenging
situations, dual-task walking is commonplace and critical to
functional independence. Interestingly, although dual-task
walking is presumed to be ubiquitous, an estimate describ-
ing how common it is does not yet exist. Thus, its impact
on daily-living walking can only be inferred.
Body-worn sensors, also referred to as wearables, now
provide an inexpensive opportunity for the continuous
monitoring of ambulatory activity in free-living environ-
ments [7, 9, 33–39]. The basic elements of gait are simi-
lar regardless of where a subject is tested. Yet, like the
ambulatory monitoring of real-world arrhythmias and
seizures, multi-day, continuous recordings of gait puta-
tively provide metrics that capture the complexities and
multiple influences on real-world gait [40] that are not
fully reflected when subjects are assessed in the labora-
tory or clinic. These every-day influences likely include
dual and multi-tasking, planning, obstacle negotiation,
fatigue, motivation, mind wandering, and mood. Previ-
ous studies using wearables to assess daily-living gait
have shown the value of such measurements, for ex-
ample, in predicting future falls among older adults [7,
33–39, 41]. At the same time, a growing body of literature
suggests that the values of the gait measures extracted
from daily-living differ from those extracted during testing
in the laboratory [7, 10, 11, 33, 39, 42–46]. The reasons
for this gap are, however, not yet fully clear.
Previous studies have generally compared in-lab usual
walking to daily-living measures, however, a direct com-
parison of in-lab dual tasking gait to daily-living gait has
not yet been conducted. We speculate that perhaps the
dual- and multi-tasking that occurs during daily-living
may contribute to the gaps between in-lab usual walking
and daily-living walking. As a step toward better under-
standing the gaps between in-lab gait and daily-living gait,
here we sought to examine the role of dual-tasking. In
particular, in the present study, we directly compare in-lab
to daily-living gait in older adults with a history of falls in
order to elucidate the relationship between the measures
obtained in each setting and to gain insight into
daily-living walking. We focused on five spatial-temporal
gait features that are commonly used to evaluate and
characterize in-lab usual walking and in-lab dual-task
walking and sought to address the following questions: Is
daily-living gait comparable to usual walking, as measured
in the laboratory? Stated alternatively, is daily-living gait,
which typically takes place in a complex, cognitively chal-
lenging environment, more similar to dual-task walking as
measured in the laboratory? About how much of
daily-living walking is worse than in-lab dual-task
walking?
Methods
Participants
The present analysis is based on the baseline assessment
of subjects who participated in V-TIME, a multi-center
(5 clinical sites), randomized controlled trial designed to
reduce fall rates in older adults [47]. Briefly, individuals
were enrolled if they were aged 60–90 years, on stable
medications for the past month, able to walk for at least
5 min unassisted, and had at least 2 falls in the previous
6 months. Individuals were excluded if they had psychi-
atric comorbidity (e.g., major depressive disorder as in
accordance with DSM IV criteria); history of stroke,
traumatic brain injury, or other neurological disorders
(not including mild cognitive impairment); acute lower
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back or lower extremity pain; peripheral neuropathy;
rheumatic and orthopedic diseases; or a clinical diagnosis
of dementia or severe cognitive impairment (Mini Mental
State Exam score < 21). Subjects were characterized by
age, gender, body-mass-index, and years of education. In
addition, the Montreal Cognitive Assessment (MOCA)
evaluated general cognitive function [48] (best possible
score 30), the SF-36 assessed general health and physical
function [49], and the Falls Efficacy Scale-International
(FES-I) evaluated fear of falling (best and worst possible
scores 16 and 64, respectively) [50]. The Short Physical
Performance Battery (SPPB) (best possible score 12) [51],
Mini-Balance Evaluation Systems Test (MINI-BEST) (best
possible score 32) [52], and the Four Square Step Test
(FSST) [53] assessed multiple aspects of balance, gait, and
mobility in the lab.
In-lab assessment of gait
Participants walked back and forth in a well-lit, 15-m
long corridor for 1 min under two walking conditions:
(1) preferred, usual walking speed and (2) dual-task
walking, i.e., while serially subtracting 3s from a prede-
fined 3-digit number while walking, with no explicit task
prioritization. The testing order was fixed. To quantify
gait, a lightweight body-fixed sensor (Opal APDM, Port-
land, Oregon) was attached with a belt to the lower back
(lumbar vertebrae 4–5). The sensor includes a tri-axial
accelerometer, gyroscope, and magnetometer (unit
weight 22 g; unit size 48.5 mm × 36.5 mm × 13.5 mm;
128 Hz sampling rate).
Daily-living assessment of gait
At the end of the laboratory testing session, participants
were asked to wear a tri-axial accelerometer (Axivity
AX3, York, UK; dimensions: 23.0 × 32.5 × 7.6 mm;
weight: 11 g; 100 Hz sampling rate) for one week. The
device was held in place with skin tape to the lower back
(lumbar vertebrae 4–5). The participants were instructed
to leave the device on throughout the week and to con-
tinue their daily activities as usual and not to change
their routine. Upon completion of the recording, partici-
pants removed the device and mailed it back to one of
the study sites for data processing.
Data processing and analysis of gait
The data analysis of the daily-living recordings included
two stages: 1) Detection of all 30-s walking bouts [58];
and 2) Determination of the gait features in each bout,
using the same algorithms as those used for in-lab test-
ing. We focused on 30-s walking bouts, as this relatively
long length most likely reflects purposeful, steady-state
walking assessed in the lab and because relatively long
walking episodes are more relevant for assessing walking
quality [11, 34, 38, 39, 54]. The outcome measures for
both in-lab and daily-living included step time, step
length, gait speed, fundamental spatial-temporal gait
measures, and were determined as previously described
[55–58]. We also assessed step regularity, a measure of
gait asymmetry (lower values reflect greater asymmetry)
and stride regularity, a measure of the consistency of the
walking pattern (higher values reflect greater
stride-to-stride consistency and lower values reflect
greater stride-to-stride variability) [59]. For each subject
and for each feature, a histogram based on the value in
all 30-s walking bouts was determined and then from
this, each subject’s typical (percentile 50, median), worst
(percentile 10) and the best (percentile 90) values over
the week were determined (see Fig. 1 for an example). It
should be noted that the terms “worst” and “best” are
based on labels and interpretations that are usually
applied to gait testing in the lab, however, it is not yet
fully clear how to apply these terms to measures taken
in daily life. In parallel, the outcome measures were ex-
tracted for laboratory walking bouts after removing
turns and the first and last 3 steps of every walking bout
to minimize start (i.e., acceleration and end (i.e., deceler-
ation) effects [60]. Finally, we compared the features ex-
tracted from daily-living walking bouts to the in-lab
usual and dual-task walking.
Statistical analyses
Statistical analyses were carried out using SPSS v25
(SPSS Inc., Chicago, IL). To obtain an accurate assess-
ment of daily-living walking, only subjects who had
more than 3 days of data were included in the analyses
[11]; thus 150 out of a possible 164 subjects were ana-
lyzed. Descriptive statistics (means and SD) were calcu-
lated for gait and subject characteristics. Outliers,
defined as values more than three times the interquartile
range, were identified and removed. Paired t-tests were
used to examine the relationship between each subject’s
typical, best, and worst daily-living walking bouts, on the
one hand, and each subject’s in-lab usual walking and
dual-task walking, on the other hand. To minimize the
effects of multiple comparisons, p values < 0.001 were
considered as significantly different. Statistics of reliabil-
ity were assessed using Intraclass Correlation Coeffi-
cients (ICC2, 1) (two way mixed, absolute, single
measures). ICCs values lower than 0.50 indicate poor re-
liability, values between 0.50 and 0.75 indicate moderate
reliability, values between 0.75 and 0.90 indicate good
reliability and values greater than 0.90 indicate excellent
reliability [61].
Results
Subject characteristics are summarized in Table 1. The sub-
jects had mild to moderate deficits in cognitive function,
balance and physical performance. These characteristics are
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consistent with that expected of older adult fallers. The
light-blue bars in Fig. 2 reflect the in-lab measures of
usual-walking and dual-task walking. In-lab gait speed dur-
ing usual walking was 100.5 ± 21.5 cm/s, consistent with
that of older adults with mild to moderate impairment. As
anticipated, during the in-lab testing, a significant dual-task
effect was seen. For example, in-lab dual-tasking gait speed
was lowered (p < 0.0001) to 94.7 ± 22.2 cm/s. During in-lab
dual-tasking, step time did not change significantly (p =
0.146), however, step length, step regularity, and stride re-
gularity were significantly (p < 0.0001) lower (i.e., worse)
compared to in-lab usual-walking.
Figure 2 summarizes the relationship between the gait
values of daily-living worst, typical and best walking bouts
and the in-lab measures of usual and dual-task walking. As
seen in Fig. 2a, in-lab step length during usual-walking was
similar (p = 0.516) to the typical daily-living value, higher
than the daily-living worst, and lower than the best
daily-living values (p < 0.0001). In-lab dual-task step length
differed from the best, worse, and typical daily-living values
(p < 0.0001). Gait speed during in-lab dual-task walking was
similar (p = 0.205) to daily-living typical walking, while
in-lab usual-walking gait speed was significantly different
from the best (p < 0.0001), worst (p < 0.0001), and typical
daily-living (p = 0.004) values (Fig. 2b). For step regularity
and stride regularity, in-lab usual walking differed from the
best, worse, and typical daily-living values (p < 0.0001),
while dual-task walking tended to be similar to typical
daily-living values (p = 0.053, p = 0.013 respectively) (see
Fig. 2c and Fig. 2d), parallel to what was seen for gait speed.
For step time, in-lab usual walking step time and in-lab
dual-task walking values were similar to each other
Fig. 1 An example histogram from one subject of the values of gait speed obtained during 30-s walking bouts across the week during the daily-
living recording. The subject’s typical (50%) gait speed was 98 cm/sec, the worst (10%) was 77 cm/sec and the best (90%) was 113 cm/sec. The
use of descriptors “worst” and “best” is according to in-lab terminology where higher = better and lower = worst. These labels may not be appropriate
when they are applied to some daily-living conditions (e.g., when walking on a wet, slippery surface, a slower gait speed and a shorter step length
may actually be the most appropriate behavior and not the “worst” behavior)
Table 1 Subject characteristics*
(N = 150)
Age (yrs) 76.5 ± 6.3
Gender (% men) 37.6
Height [cm] 164 ± 8.83
Education (yrs) 12.8 ± 3.9
Body Mass Index (BMI) (kg/m2) 26.2 ± 4.4
Montreal Cognitive Assessment 24.5 ± 3.6
SF-36 General Health 61.3 ± 18.5
Falls Efficacy Scale – International 28.7 ± 8.3
Mini Best Test of Balance (MiniBest) 21.9 ± 6.1
Four Square Step Test (FSST) 12.4 ± 6.8
Short Physical Performance Battery (SPPB) 9.1 ± 2.3
Number of falls in the previous 6 months 2 (2,7)
*Entries are mean ± SD, median (percentile 10, percentile 90), or % as indicated
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Fig. 2 In-lab usual-walking and in-lab dual-task walking compared to daily-living walking typical, best and worst gait values of: a) step length; b) gait
speed; c) step regularity; d) stride regularity and e) step time. The light blue bars reflect the in-lab values of usual-walking (UW) and dual-task
walking (DTW). The results shown here are based on 30-s walking bouts
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and similar (p > 0.094) to the typical daily-living value
(see Fig. 2e).
Table 2 summarizes the results of the agreement ana-
lyses comparing in-lab and daily-living walking bouts as
evaluated using ICC and Pearson’s correlation coefficients
for all five gait features. There was good agreement be-
tween the values of step length during typical daily-living
walking and in-lab usual-walking and moderate agreement
with in-lab dual-task walking. For gait speed, step regular-
ity, stride regularity and step time, there was poor to mod-
erate agreement between in-lab values (both usual and
dual-task walking) with the typical values obtained during
daily-living. Example scatter plots and Bland-Altman plots
are shown in Fig. 3 for step length and gait speed, showing
the relationship between individual values of in-lab dual
tasking values and daily-living values. Many values of step
length differed by more than ±5 cm and many values of
gait speed differed by than 5 cm/sec (i.e., above the mean-
ingful change difference [57]). This large range around the
mean difference is consistent with the relatively high re-
producibility coefficients (higher values indicates worse
reliability) and the high coefficient of variations (CVs)
(higher indicates worse reliability) and suggests that the
in-lab values do not reliably reflect the daily-walking
values.
To estimate what percent of each subject’s daily-living
walking was worse (e.g., lower) than the corresponding
in-lab usual and dual-task walking values, the
daily-living values were ranked and determined as a per-
centile (from 0 to 100, lowest to highest). This allowed
Table 2 Agreement analyses comparing in-lab features of usual and dual-task walking, on the one hand, and daily-living features,
on the other hand, as measured using the intraclass correlation coefficient analyses (two way mixed, absolute, single measure)*
Hillel et al. European Review of Aging and Physical Activity            (2019) 16:6 Page 6 of 12
us to estimate how the subject’s in-lab values compare
(rank) compared to his / her daily-living values. Figure 4
shows an example of gait speed and step regularity
daily-living values ranked across all 30-s walking bouts
along with the corresponding in-lab usual (green line)
and dual-task (red line) values. In this example, in-lab
usual walking and dual-tasking gait speed were 106.16
cm/sec and 91.71 cm/sec. This corresponds to the 94
percentile and 60 percentile, respectively, of the
daily-living values of gait. In other words, in 94% of all
daily-living walking bouts, his gait speed was lower than
in-lab usual walking gait speed and in 60% of all
daily-living walking bouts, his gait speed was lower than
in-lab dual-tasking gait speed.
Table 3 summarizes the percentage of the daily-living
walking bouts whose values were worse than those
in-lab usual and in-lab dual-task walking values. Aver-
aged across all subjects, daily-living gait speed was lower
than in-lab usual walking gait speed in 64% of the
daily-living walking bouts and daily-living gait speed was
Fig. 3 Scatter plots and Bland Altman plots illustrating the relationship between in-lab dual-task step length (a) and gait speed (b) and the daily-
living features observed in 30-s walking bouts. CV: coefficient of variance; RPC: reproducibility coefficient (1.96*SD)
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lower than in-lab dual-tasking gait speed in 51% of the
walking bouts. To provide an overall summary and gen-
eral impression, we averaged these percentages across all
five gait features. 65% of the daily-living walks were
lower than in-lab usual walk and about 55% of the
daily-living walks were lower than in-lab dual-task walk
(fairly similar to the values for the individual features).
In other words, the in-lab measures of gait are better
than a large percent of daily-living walking.
Discussion
In this cross-sectional study among 150 community-living
older adults with mild to moderate deficits in cognitive
function, balance and physical performance and multiple
falls, we directly compared five commonly used
Fig. 4 An example of a) gait speed and b) step regularity for a single subject’s 30-s daily-living walking bouts and his in-lab usual (green line)
and dual-task (red line) values
Table 3 Ranking of in-lab usual walking and in dual-task walking
with respect to daily-living 30-s walking bouts*
In-lab usual walking In-lab dual-task walking
Step length 53.5 ± 23.1% 45.1 ± 22.9%
Gait speed 63.8 ± 23.3% 50.9 ± 25.4%
Step regularity 73.2 ± 26.6% 64.1 ± 27.5%
Stride regularity 72.3 ± 23.7% 62.1 ± 25.8%
Step time 63.8 ± 25.9% 55.1 ± 29.9%
Average 65.3 ± 24.5% 55.4 ± 26.3%
*Entries are mean ± SD. The values indicate that among 50.9% of all daily-
living walking bouts, gait speed was lower than that seen during in-lab dual-
task walking, for example
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spatial-temporal features of gait quality, as measured in the
lab, to the corresponding values obtained during
daily-living. When examining relatively long walking bouts
(i.e., 30 s), we found three key findings: 1) the group mean
values obtained in the lab during dual-task walking are gen-
erally similar to the values obtained during daily-living, at
least on a group level; however, 2) the specific in-lab mea-
sures do not reliably reflect daily-living measures, as seen
by the ICC analysis (with the exception of step length in
usual walk which is in good agreement with typical
daily-living value); 3) more than 50% of the walks in
daily-living conditions are worse than the corresponding
dual-task values as measured in the laboratory, which is
worse than the values obtained during usual-walking in the
laboratory.
In general, the comparison between daily-living and
in-lab gait features revealed that most gait features obtained
during daily-living were closer in value to the dual-task
values measured in the laboratory setting (recall Fig. 2).
Consistent with this finding, the usual-walking measures
obtained in the laboratory tended to be much better than
the typical values obtained during daily-living (recall Fig. 2),
for most walking bouts (recall Table 3). At the same time,
the intraclass correlation coefficients (Table 2) showed poor
to good agreement in all the features, suggesting that the
values obtained in the lab do not reliably reflect or agree
with the same measures obtained during daily-living. In-
deed, in the Bland-Altman plot of gait speed (Fig. 3b), many
of the data points are above the meaningful change differ-
ence of 5 cm/sec [62], illustrating that differences between
the in-lab and daily-living values are relatively large. Thus,
while dual-tasking in-lab measures are apparently closer to
the values determined from daily-living, one is still not a
simple mirror image of the other.
In the present study, we focused on the role of one
factor that putatively contributes to the gaps between
in-lab usual-walking gait and daily-living gait, i.e.,
dual-tasking. Cognitive-motor and motor-motor dual
and multi-tasking are common in daily life, e.g., walking
while talking, while using a mobile phone, while carrying
a bag, or while watching or negotiating traffic. It is now
increasingly recognized that performing two or more
tasks simultaneously negatively impacts the gait per-
formance of older adults and that this change is related
to adverse health outcomes in aging populations [17, 21,
23, 32, 63, 64]. Thus, dual-tasking assessments have
been added to augment short, in-lab testing in an
attempt to make them better reflect the many
motor-cognitive challenges that occur during every-day
ambulation to reveal cognitive compensatory attempts
[15–26, 65] and to enhance the ecological relevance of
the well-controlled, supervised in-lab testing. Interest-
ingly, we found that gait performance in more than 55%
of the daily-living, 30-s long walks are worse than
performance observed during controlled testing in the
laboratory, even compared with in-lab dual-task values
(Table 3 and Fig. 4). This finding implies that in-lab
measures of gait, even dual-task walking features, do not
provide an accurate reflection of daily-living gait mea-
sures. It also suggests that, as a rough approximation,
much of daily-living walking apparently involves some
factor(s) that makes the performance fall far below that
seen during the testing of usual-walking. Given the ubi-
quitous nature of dual- and multi-tasking in daily-life,
we can speculate that these everyday cognitive chal-
lenges contribute to the gap between in-lab and
daily-living gait. This possibility is consistent with recent
findings which showed that cognitive function is more
closely correlated to real-world mobility than to
laboratory-based mobility [66]. Still, future studies that
consider additional factors are needed to further tease
out this question. In the meantime, though, it appears
that in-lab usual-walking and dual-task walking perform-
ance both overestimate much of every-day
walking performance.
Other factors likely also play an important role in the
gaps between daily-living and in-lab gait. For example,
psychological factors like the Hawthorne effect [67] and
reverse white coat syndrome [68] are likely to have a posi-
tive impact on testing in the lab, with minimal impact on
daily-living gait. Factors like mood, depression, and fatigue
may negatively impact daily-living gait, more so than on
in-lab gait, where study participants may attempt to put
on their best effort, regardless of mood and fatigue. In
addition to dual-tasking, these factors may have contrib-
uted to the gaps that we observed (recall Fig. 2). These
ideas have led to the notion that testing in the laboratory
represents what the subject can do, i.e., capacity, whereas
testing during daily-living represents actual performance,
function, and behavior, and not just intrinsic abilities [66,
69, 70]. From this perspective, it may be interesting to
compare other types of walking in the laboratory, super-
vised setting (e.g., fast walking, obstacle negotiation, fa-
tigued walking) to investigate how capacity in these
conditions maps to daily-living gait.
Several additional factors to consider are the environ-
ment and the nature of the walk. In daily-living, walking
may not be along a straight-line. Curved walking has been
studied in laboratory settings. It has been shown, for ex-
ample, that multiple features of gait change during curved
walking and when turning [71–76]. In general, during
turns and curved walking, gait speed is reduced, asym-
metry increases, and the gait pattern becomes more ir-
regular, as compared to straight-line walking; all of these
changes are consistent with the finding that typical
daily-living gait values of gait speed, step regularity (i.e.,
symmetry), and stride regularity are all lower than the
values seen during testing in the laboratory (recall Fig. 2).
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In addition, since some of the algorithms used for deter-
mining gait quality features assume straight-line,
steady-state walking [59, 77], applying them directly to
daily-living walks where subjects may walk in a curve,
with sharp turns or abrupt changes in speed, might influ-
ence the results. Other environmental elements (e.g., an
inclined surface, cobblestone sidewalk, lighting) may also
contribute to the differences between in-lab and
daily-living walking. In this context, it may be helpful to
keep in mind that the terms “worst” and “best” were
chosen according to gait performance in the lab. In daily
life, however, lower and higher values may not necessarily
reflect worst and best and the interpretation of the values
may depend on the environmental conditions, for
example. Perhaps the worst walking bouts during
daily-living reflect walking in some of these environmental
conditions and are actually an appropriate response (e.g.,
slower gait speed and shorter step length on a wet, slip-
pery surface). Future work is needed to examine the im-
pact of these additional factors on the gap between in-lab
and daily-living gait. Future studies should also examine if
and how the present findings apply to other subject groups
(e.g., healthy older adults without a history of falls, older
adults with widely studied neurological conditions such as
Parkinson’s disease) and prospectively evaluate if the time
spent in relatively poor walking during daily-living (recall
Table 3) changes over time and responds to interventions.
Bout length is also an important consideration. In the
current analyses, we controlled for bout length by focus-
ing on 30-s bouts in both the laboratory and daily-living
settings. In everyday situations, most relatively
long-walks, e.g., 30 s and longer, likely occur outside of
the home (i.e., most homes do not have 30-m long
paths); in contrast, within the home or office setting,
there are many short walking bouts [34]. If steady-state
gait and walking performance are the questions of inter-
est, relatively long bouts should be evaluated, as in the
present study. At the same time, since much of
daily-living gait takes place during very short bouts (<
10 s) [33, 34, 78], these bouts should also be considered
when describing all of daily-living functioning.
Conclusions
In conclusion, the present findings suggest that in-lab
measures of gait do not accurately reflect daily-living
gait measures. This is the case for in-lab usual-walking
and also for in-lab dual-task walking. As noted in the
introduction, the assessment of usual-walking and
dual-task walking in laboratory settings is valuable,
insightful, and clinically relevant, predicting important
adverse health events. Nonetheless, the outcomes of our
analyses indicate that this snapshot picture of gait does
not accurately reflect every-day walking. Using an ana-
logy from cardiology, the present results suggest that
just as both the resting (in-lab) ECG and the continuous,
daily-living Holter monitoring are informative for asses-
sing and tracking cardiovascular risk, so too, the evalu-
ation of gait based on both in-lab and daily-living testing
apparently capture complementary aspects. Still, pro-
spective and additional studies are needed to further
demonstrate the utility of these daily-living measures of
gait, to better understand what subject characteristics
and other factor affect them and the gaps between in-lab
and daily-living measures, and to more fully evaluate
their potential in the assessment of fall risk, mobility im-
pairment, cognitive decline, and related outcomes that
affect many older adults.
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